jRCT1031240384招募中不适用
Japan post-marketing study of Peficitinib use in RA patients study-MTX tapering
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 200
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
- 性别
- All
入选标准
- •Patients aged 20 years old and older as of the index date and the reason for receiving peficitinib during peficitinib PMS (SMR001) is RA
- •Patients who were administered MTX (oral formulation: 8 mg/week higher or subcutaneous injection preparation: 7.5 mg/week higher ) concomitantly at the start of initial administration with peficitinib 100 mg or 150 mg
- •Patients who are registered to Peficitinib PMS (SMR001)
- •Patients who provided written informed consent to study participation
- •Patients who have been followed up for at least 104 weeks from the index date (including those who are discontinued before 104 weeks)
排除标准
- •Patients who were administered Peficitinib for diseases other than RA
- •Patients who were administered Peficitinib 50 mg from the index date to 104 weeks
结局指标
主要结局
-
The change in CDAI
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
CoreValve Advance, International Post Market Study A Multi-center, Interventional, Prospective, Post-Market Release Studysevere aortic valve stenosis10046973NL-OMON34858Medtronic B.V.250
进行中（未招募）
不适用
Estudio multinacional, de grupos paralelos, abierto, aleatorizado, de 24 semanas que compara Lantus® (insulina glargina) administrada por la mañana como insulina basal una vez al día con insulina NPH (Neutral Protamine Hagedorn), en niños con diabetes mellitus tipo 1 entre 1 y menos de 6 años de edad.__________________________________________________A 24-week, randomized, open-label, parallel group multinational comparison of Lantus® (insulin glargine) given in the morning as once-a-day basal insulin versus Neutral Protamine Hagedorn (NPH) insulin, in children with type 1 diabetes mellitus aged at least 1 year to less than 6 years - PRESCHOOL (PRESchool CHildren with type 1 diabetes On mOrning Lantus)Pacientes con diabetes mellitus tipo 1, entre 1 y 6 años_______________________________________________Patients with type 1 diabetes mellitus, aged at least 1 year to less than 6 yearsMedDRA version: 12.0Level: LLTClassification code 10012609Term: <Manually entered code. Term in E.1.1>EUCTR2009-011231-12-ESsanofi-aventis recherche & développement90
招募中
4 期
Post Market Clinical Follow Up of Skanrays Fixed X-ray Systems (Clinical study to record the safety and performance data of Skanrays Fixed X-ray Systems in real world scenario)CTRI/2022/12/047864Skanray Technologies Limited
已完成
4 期
Post Market Clinical Follow Up of Skanray s Patient MonitorsCTRI/2022/05/042811Skanray Technologies Limited
已完成
不适用
Post Market Clinical Follow Up Investigation of Intraskan DCCTRI/2020/12/029746Skanray Technologies Pvt Ltd